New hope for Hard-to-Treat cancers: experimental drug VT3989 enters human trials
Disease control
Recruiting now
This study is testing an experimental drug called VT3989, taken as a pill once a day, for people with advanced solid tumors or mesothelioma that have stopped responding to standard treatments. The goal is to find safe doses and see if the drug can shrink tumors or slow cancer gro…
Phase: PHASE1, PHASE2 • Sponsor: Vivace Therapeutics, Inc • Aim: Disease control
Last updated May 26, 2026 12:02 UTC